Literature DB >> 10855686

Circulating endothelium-related adhesion molecules in black South African patients with Graves' disease.

V R Panz1, F J Raal, J R Wall, B I Joffe.   

Abstract

Elevated serum concentrations of endothelium-associated adhesion molecules occur in Graves' disease. However, no data exist in African subjects, among whom the incidence is rising. Therefore, 20 black South Africans with Graves' hyperthyroidism were evaluated and 10 healthy controls were also studied. Quantitative determinations of soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), and soluble E-Selectin (sE-Selectin) were performed in serum samples by an enzyme-linked immunosorbent assay. Mean levels of sVCAM-1 were significantly increased in the thyrotoxic patients compared to controls, but this did not apply to the other adhesion molecules. The presence of ophthalmopathy in 12 patients did not further increase the mean sVCAM-1 concentration, and the administration of antithyroid medication in 5 patients had no measurable effect. In conclusion, sVCAM-1 appears to be a useful marker of active Graves' disease in black South Africans although it does not seem to reflect the occurrence of eye involvement in such patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10855686     DOI: 10.1385/ENDO:12:1:21

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  14 in total

Review 1.  Structure and function of cell adhesion molecules.

Authors:  L Petruzzelli; M Takami; H D Humes
Journal:  Am J Med       Date:  1999-04       Impact factor: 4.965

2.  Classification of eye changes of Graves' disease.

Authors: 
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

Review 3.  Cell adhesion/signalling: biology and clinical applications.

Authors:  M W Makgoba; A Bernard; M E Sanders
Journal:  Eur J Clin Invest       Date:  1992-07       Impact factor: 4.686

4.  Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.

Authors:  O Modebe
Journal:  Afr J Med Med Sci       Date:  1995-12

5.  Thyrotoxicosis in urban black Africans: a rising incidence.

Authors:  W J Kalk
Journal:  East Afr Med J       Date:  1981-02

6.  Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.

Authors:  C Wenisch; D Myskiw; A Gessl; W Graninger
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

7.  Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy.

Authors:  M Zouvanis; V R Panz; W J Kalk; B I Joffe
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

8.  Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies.

Authors:  B Joffe; K Gunji; V Panz; M Zouvanis; J Swanson; B A Ackrell; J R Wall
Journal:  Thyroid       Date:  1998-11       Impact factor: 6.568

9.  Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.

Authors:  A E Heufelder; R S Bahn
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

10.  Soluble endothelium-associated adhesion molecules in patients with Graves' disease.

Authors:  C Wenisch; D Myskiw; B Parschalk; T Hartmann; K Dam; W Graninger
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

View more
  2 in total

1.  Thyroid-associated ophthalmopathy in black South Africans with Graves' disease: relationship to serum antibodies reactive against eye muscle and orbital connective tissue autoantigens.

Authors:  B I Joffe; V R Panz; M Yamada; J R Wall
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.